Avera vCNE Acute Care Series - Drug Diversion in the Health Care Setting (Enduring Material)

Instructions to Receive Credit

Wednesday, December 16, 2020, 12:00 AM - Monday, August 30, 2021, 11:59 PM

There is no cost for this educational activity.

This session will increase the acute care nurse's awareness of drug diversion's significant effect and possible consequences. The session will also focus on current strategies and continued tactics regarding prevention and detection of drug diversion in the hospital setting.

1. Identify the impact and consequences of drug diversion by a healthcare professional.
2. Evaluate current and future strategies for prevention and detection of drug diversion.
3. 50% of nurses can self-report a change in practice within 90 days of education related to drug diversion

ADA accommodations will be made in accordance with the law. If you require ADA accommodations, please indicate what your needs are at the time of registration. We cannot ensure the availability of appropriate accommodations without prior notification.

Avera is accredited as a provider of nursing continuing professional development by the American Nurses Credentialing Center's Commission on Accreditation.  A total of 1.0 contact hours can be received upon completion of this education activity. Attendance at the entire educational activity is required to receive contact hours.

This program has been granted prior approval by the American Association of Medical Assistants (AAMA) for 1 administrative continuing education unit(s). Granting approval in no way constitutes endorsement by the AAMA of the program content or the program provider.

Mitigation of Relevant Financial Relationships

Avera adheres to the Standards for Integrity and Independence in Accredited Continuing Education.  Any individuals in a position to control or influence the content of a CE activity, including but not limited to faculty, planners, authors, and reviewers are required to disclose all relevant financial relationships with an ineligible companies. All relevant financial relationships have been mitigated.